← Back to Patent Explorer
US5508272A Expired / Lapsed US ⏱️ 0.0 years remaining

Compounds containing a fused bicycle ring and processes therefor

Assignee: Bristol Myers Squibb Co
•
Filing: 1994-05-05
•
Granted: 1996-04-16
•
Expires: 2014-05-05
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Compounds of the formula <IMAGE> wherein X is O or S-(O)t; n is one or two; m is zero or one; Y is CH2, O, or S-(O)t provided that Y is O or S-(O)t only when m is one; and A is <IMAGE> are dual inhibitors of NEP and ACE. Compounds wherein A is <IMAGE> are selective ACE inhibitors. Also disclosed are methods of preparation and intermediates.

Inventors

  • 👤 Jeffrey A. Robl

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-05 18:21
CPC Classifications
C; C07; C07D; C07D513/00; C07D513/02; C07D513/04; A; A61; A61P; A61P43/00; A61P9/00; A61P9/04; A61P9/12; C07C; C07C227/00; C07C227/30; C07C227/32; C07C315/00; C07C315/02; C07C319/00; C07C319/14; C07C319/20; C07C327/00; C07C327/20; C07C327/32; C07C327/34; C07D498/00; C07D498/02; C07D498/04; C07K; C07K5/00; C07K5/04; C07K5/06; C07K5/06139; A61K; A61K38/00; C07B; C07B2200/00; C07B2200/07; Y; Y02; Y02P; Y02P20/00; Y02P20/50; Y02P20/55

Claims Analysis

Total Claims: 41
Claim 1
Independent Claim 321 words
A compound of the formula ##STR87## or a pharmaceutically acceptable salt thereof wherein: A is ##STR88## X is O or S-(O) t ; R 1 and R 12 are independently selected from the group consisting of hydrogen, alkyl, alkenyl, cycloalkyl, substituted alkyl, substituted alkenyl, aryl, substituted aryl, heteroaryl, cycloalkyl- alkylene-, aryl-alkylene-, substituted aryl- alkylene-, and heteroaryl-alkylene- or R 1 and R 12 taken together with the carbon to which they are attached complete a cycloalkyl ring or a benzolused cycloalkyl ring; R 2 is hydrogen, ##STR89## or R 11 -S-; R 3 , R 5 and R 7 are independently selected from the group consisting of hydrogen, alkyl, substituted alkyl, aryl- (CH 2 ) p-, substituted aryl- (CH 2 ) p -, heteroaryl-(CH 2 ) p - , ##STR90## R 4 is alkyl, cycloalkyl-(CH 2 ) p -, substituted alkyl, aryl-(CH 2 ) p -, substituted aryl-(CH 2 ) p -, or heteroaryl-(CH 2 ) p -; R 6 is alkyl, substituted alkyl, cycloalkyl-(CH 2 ) p -, aryl- (CH 2 ) p -, substituted aryl-(CH 2 ) p -, or heteroaryl-(CH 2 ) p -; R 8 is hydrogen, lower alkyl, cycloalkyl, or phenyl; R 9 is hydrogen, lower alkyl, lower alkoxy, or phenyl; R 10 is lower alkyl or aryl-(CH 2 ) p -; R 11 is hydrogen, alkyl, substituted alkyl, cycloalkyl-(CH 2 ) p -, aryl- (CH 2 ) p -, substituted aryl-(CH 2 ) p -, heteroaryl-(CH 2 ) p -, or -S-R 11 completes a symmetrical disulfide wherein R 11 is ##STR91## m is zero or one; Y is CH 2 , S-(O) t or O provided that Y is S-(O) t or O only when m is one; n is one or two; p is zero or an integer from 1 to 6; q is zero or an integer from 1 to 3; r is zero or one; and t is zero, one, or two.
Claim 2
Dependent Claim 321 words
A compound of the formula ##STR87## or a pharmaceutically acceptable salt thereof wherein: A is ##STR88## X is O or S-(O) t ; R 1 and R 12 are independently selected from the group consisting of hydrogen, alkyl, alkenyl, cycloalkyl, substituted alkyl, substituted alkenyl, aryl, substituted aryl, heteroaryl, cycloalkyl- alkylene-, aryl-alkylene-, substituted aryl- alkylene-, and heteroaryl-alkylene- or R 1 and R 12 taken together with the carbon to which they are attached complete a cycloalkyl ring or a benzolused cycloalkyl ring; R 2 is hydrogen, ##STR89## or R 11 -S-; R 3 , R 5 and R 7 are independently selected from the group consisting of hydrogen, alkyl, substituted alkyl, aryl- (CH 2 ) p-, substituted aryl- (CH 2 ) p -, heteroaryl-(CH 2 ) p - , ##STR90## R 4 is alkyl, cycloalkyl-(CH 2 ) p -, substituted alkyl, aryl-(CH 2 ) p -, substituted aryl-(CH 2 ) p -, or heteroaryl-(CH 2 ) p -; R 6 is alkyl, substituted alkyl, cycloalkyl-(CH 2 ) p -, aryl- (CH 2 ) p -, substituted aryl-(CH 2 ) p -, or heteroaryl-(CH 2 ) p -; R 8 is hydrogen, lower alkyl, cycloalkyl, or phenyl; R 9 is hydrogen, lower alkyl, lower alkoxy, or phenyl; R 10 is lower alkyl or aryl-(CH 2 ) p -; R 11 is hydrogen, alkyl, substituted alkyl, cycloalkyl-(CH 2 ) p -, aryl- (CH 2 ) p -, substituted aryl-(CH 2 ) p -, heteroaryl-(CH 2 ) p -, or -S-R 11 completes a symmetrical disulfide wherein R 11 is ##STR91## m is zero or one; Y is CH 2 , S-(O) t or O provided that Y is S-(O) t or O only when m is one; n is one or two; p is zero or an integer from 1 to 6; q is zero or an integer from 1 to 3; r is zero or one; and t is zero, one, or two.
Claim 3
Dependent Claim 9 words
A compound of claim 1 having the formula ##STR92##
Claim 4
Dependent Claim 7 words
A compound of claim 2 wherein: ##STR93##
Claim 5
Dependent Claim 150 words
A compound of claim 3 wherein: R 2 is hydrogen, ##STR94## or R 11 -S-; R 3 is hydrogen or lower alkyl of 1 to 4 carbons; r is zero or one; R 11 is lower alkyl or 1 to 4 carbons; R 1 is aryl-CH 2 -, substituted aryl-CH 2 -, heteroaryl-CH 2 -, cycloalkyl-CH 2 - wherein cycloalkyl is of 3 to 7 carbons, or straight or branched chain alkyl of 1 to 7 carbons and R 12 is hydrogen; or R 1 and R 12 taken together with the carbon to which they are attached complete a cycloalkyl ring of 5 to 7 carbons; R 6 is lower alkyl of 1 to 4 carbons or phenyl; m is zero or one; X is O or S; and Y is CH 2 , O, or S provided that Y is O or S only when m is one.
Claim 6
Dependent Claim 72 words
A compound of claim 3 wherein: R 2 is hydrogen or ##STR95## R 3 is hydrogen; r is zero or one; R 1 is benzyl, cyclopropylmethyl, or straight or branched chain alkyl of 3 to 5 carbons; R 12 is hydrogen; m is zero or one; X is O or S; and Y is CH 2 , O, or S provided that Y is O or S only when m is one.
Claim 7
Dependent Claim 18 words
A compound of claim 5 wherein: X is S; Y is CH 2 ; m i s one.
Claim 8
Dependent Claim 22 words
A compound of claim 6 wherein: r is zero; R 2 is hydrogen; R 1 is benzyl; and R 12 is hydrogen.
Claim 9
Dependent Claim 10 words
The compound of claim 7, [4S-[4α(R*) , 7α,10aβ]]-octahydro-4-[(2-mercapto-1-oxo-3-phenylpropyl) amino]-5-oxo-7H-pyrido[2,1-b][1,3]thia-zepine-7-carboxylic acid.
Claim 10
Dependent Claim 11 words
The compound of claim 7, [4S-[4β(R*), 7α, 10aβ]]-octahydro-4-[(2-mercapto-1-oxo-3-phenyl-propyl) amino]-5-oxo-7H-pyrido[2,1-b][1,3]thiazepine-7-carboxylic acid,1,1-dimethylethylamine salt.
Claim 11
Dependent Claim 10 words
The compound of claim 7, [4S-[4α(S*), 7α, 10aβ]]-octahydro-4-[(2-mercapto-1-oxo-3-phenylpropyl) amino]-5-oxo-7H-pyrido[2,1-b][1,3]-thiazepine-7-carboxylic acid.
Claim 12
Dependent Claim 22 words
A compound of claim 6 wherein: r is one, R 2 is hydrogen; R 1 is benzyl; and R 12 is hydrogen.
Claim 13
Dependent Claim 8 words
The compound of claim 11, [4S-[4α(R*), 7α,10aβ]]-octahydro-4-[[2-(mercaptomethyl)-1-oxo-3-phenylpropyl]amino]-5-oxo-7H-pyrido[2,1-b][1,3]-thiazepine-7-carboxylic acid.
Claim 14
Dependent Claim 22 words
A compound of claim 6 wherein: r is zero; R 2 is hydrogen; R 1 is isobutyl; and R 12 is hydrogen.
Claim 15
Dependent Claim 8 words
The compound of claim 13, [4S-[4α(R*), 7α,10aβ]]-octahydro-4-methyl-1-oxopentyl)amino]-5-oxo-7H-pyrido[2,1-b][1,3]thiazepine-7-carboxylic acid.
Claim 16
Dependent Claim 18 words
A compound of claim 5 wherein: X is S; Y is CH 2 ; and m is zero.
Claim 17
Dependent Claim 33 words
A compound of claim 15 wherein: r is zero; R 2 is hydrogen; R 1 is benzyl, cyclopropylmethyl, n-butyl, isobutyl, n-propyl, --CH 2 --C(CH 3 ) 3 , and R 12 is hydrogen.
Claim 18
Dependent Claim 27 words
The compound of claim 16, [4S-[4α(R*), 7α, 9aβ]]-octahydro-4-[(2-mercapto-1-oxo-3-phenylpropyl) amino]-5-oxopyrrolo[2,1-b][1,3]thiazepine-7-carboxylic acid; [4S-[4α(R*),7α, 9aβ]]-octahydro-4-[(3-cyclo-propyl-2-mercapto-1-oxopropyl)amino]-5-oxopyrrolo-[2,1-b][1,3]thiazepine-7-carboxylic acid; [4S-[4α(R*), 7α, 9aβ]]-octahydro-4-[(2-mercapto-1-oxohexyl)amino]-5-oxopyrrolo[2,1-b][1,3]-thiazepine-7-carboxylic acid; [4S-[4α(R*),7α, 9aβ]]-octahydro-4-[(2-mercapto-1-oxo-4-methylpentyl)amino]-5-oxopyrrolo[2,1-b]-[1,3]thiazepine-7-carboxylic acid; [4S-[4α(R*),7α, 9aβ]]-octahydro-4-[(2-mercapto-1-oxopentyl)amino]-5-oxopyrrolo[2,1-b][1,3]-thiazepine-7-carboxylic acid; or [4S-[4α(R*),7α, 9aβ]]-octahydro-4-[(2-mercapto-4,4-dimethyl-1-oxopentyl)amino]-5-oxopyrrolo[2,1-b]-[1,3]thiazepine-7-carboxylic acid.
Claim 19
Dependent Claim 18 words
A compound of claim 5 wherein: X is O; Y is CH 2 ; and m is one.
Claim 20
Dependent Claim 22 words
A compound of claim 18 wherein: r is zero; R 2 is hydrogen; R 1 is benzyl; and R 12 is hydrogen.
Claim 21
Dependent Claim 8 words
The compound of claim 19, [4S-[4α(R*), 7α,10aβ]]-octahydro-4-[(2-mercapto-1-oxo-3-phenylpropyl)amino]-5-oxo-7H-pyrido[2,1-b][1,3]oxa-zepine-7-carboxylic acid.
Claim 22
Dependent Claim 18 words
A compound of claim 5 wherein: X is O; Y is CH 2 ; and m is zero.
Claim 23
Dependent Claim 22 words
A compound of claim 21 wherein: r is zero; R 2 is hydrogen; R 1 is benzyl; and R 12 is hydrogen.
Claim 24
Dependent Claim 9 words
The compound of claim 22, [4S-[4α(R*), 7α, 9aβ]]-octahydro-4-[(2-mercapto-1-oxo-3-phenylpropyl)amino]-5-oxopyrrolo[2,1-b][1,3]oxa-zepine-7-carboxylic acid.
Claim 25
Dependent Claim 16 words
A compound of claim 5 wherein: X is O; Y is O; and m is one.
Claim 26
Dependent Claim 22 words
A compound of claim 24 wherein: r is zero; R 2 is hydrogen; R 1 is benzyl; and R 12 is hydrogen.
Claim 27
Dependent Claim 8 words
The compound of claim 25, [4S-[4α(R*), 7α,10aβ]]-octahydro,4-[(2-mercapto-1-oxo-3-phenylpropyl)amino]-5-oxo[1,4]oxazino[3,4-b][1,3]-oxazepine-7-carboxylic acid.
Claim 28
Dependent Claim 16 words
A compound of claim 5 wherein: X is S; Y is O; and m is one.
Claim 29
Dependent Claim 22 words
A compound of claim 27 wherein: r is zero; R 2 is hydrogen; R 1 is benzyl; and R 12 is hydrogen.
Claim 30
Dependent Claim 8 words
The compound of claim 28, [4S-[4α(R*), 7α,10aβ]]-octahydro-4-[(2-mercapto-1-oxo-3-phenylpropyl)amino]-5-oxo[1,4]oxazino[3,4-b][1,3]-thiazepine-7-carboxylic acid.
Claim 31
Dependent Claim 52 words
A pharmaceutical composition useful in the treatment of cardiovascular disease such as hypertension and congestive heart failure comprising a pharmaceutically acceptable carrier and one or more compounds of the formula ##STR96## or a pharmaceutically acceptable salt thereof wherein A, X, Y, n, m and R 3 are as defined in claim 1.
Claim 32
Dependent Claim 29 words
A method of treating cardiovascular diseases such as hypertension and congestive heart failure in a mammalian species which comprises administering an effective amount of the composition of claim 30.
Claim 33
Dependent Claim 68 words
A compound of the formula ##STR97## or a salt thereof wherein: X is O or S; n is two; m is zero or one; Y is CH 2 , O or S provided that Y is O or S only when m is one; R 3 is hydrogen, lower alkyl, or aryl --(CH 2 ) p --; and p is zero or an integer from 1 to 6.
Claim 34
Dependent Claim 68 words
A compound of the formula ##STR97## or a salt thereof wherein: X is O or S; n is two; m is zero or one; Y is CH 2 , O or S provided that Y is O or S only when m is one; R 3 is hydrogen, lower alkyl, or aryl --(CH 2 ) p --; and p is zero or an integer from 1 to 6.
Claim 35
Dependent Claim 9 words
A compound of claim 32 having the formula ##STR98##
Claim 36
Dependent Claim 22 words
The compound of claim 33 wherein: X is O; Y is CH 2 ; m is one; and R 3 is methyl.
Claim 37
Dependent Claim 22 words
The compound of claim 33 wherein: X is S; Y is CH 2 ; m is one; and R 3 is methyl.
Claim 38
Dependent Claim 22 words
The compound of claim 33 wherein: X is O; Y is CH 2 ; m is zero; and R 3 is methyl.
Claim 39
Dependent Claim 22 words
The compound of claim 33 wherein: X is S; Y is CH 2 ; m is zero; and R 3 is methyl.
Claim 40
Dependent Claim 20 words
The compound of claim 33 wherein: X is O; Y is O; m is one; and R 3 is methyl.
Claim 41
Dependent Claim 20 words
The compound of claim 33 wherein: X is S; Y is O; m is one; and R 3 is methyl.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1999-04-16 1999-10-16 2000-04-16 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2003-04-16 2003-10-16 2004-04-16 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2007-04-16 2007-10-16 2008-04-16 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag